GeneTherapyLive: Non-Viral Gene Therapy Eases Treatment Burden in Wet AMD

GeneTherapyLive: Non-Viral Gene Therapy Eases Treatment Burden in Wet AMD

GeneTherapyLive: Non-Viral Gene Therapy Eases Treatment Burden in Wet AMD 150 150 Eyevensys

A non-viral gene therapy sustained drug-delivery product that delivers anti-VEGF to the eye may replace the need for repeated intravitreal anti-VEGF injections and improve vision in patients with wet AMD.

Read More

Can Gene Therapy Cure Blindness?
Eyevensys Raises $12M in a Series B Plus Funding Round
Start Typing